Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
AIMS/HYPOTHESIS: The aim of the study is to describe the time trend of type 2 diabetes incidence in the largest state of Germany, Bavaria, from 2012 to 2021, and to compare the incidence rates during the pandemic period (2020-2021) to the pre-pandemic period (2012-2019). METHODS: This secondary data analysis uses health claims data provided by the Bavarian Association of Statutory Health Insurance Physicians (KVB), covering approximately 11 million insurees, accounting for 85% of the total population of Bavaria, Germany. Newly diagnosed type 2 diabetes cases in adults (≥20 years) coded as E11 (Diabetes mellitus, Type 2) or E14 (Unspecified diabetes mellitus) under ICD-10, German modification (ICD-10-GM) for the study period 2012 to 2021 were included. Annual and quarterly age-standardised incidence rates (ASIR) stratified by sex, age and region were calculated using the European standard population. Sex-specific crude incidence rates (CIR) were calculated using 10-year age groups. Regression analyses adjusted for time trends, seasonal effects, and pandemic effects were used to analyse the incidence trend and to assess the effect of the pandemic. RESULTS: Overall, 745,861 new cases of type 2 diabetes were diagnosed between 2012 and 2021: 50.4% (376,193 cases) in women. The male/female ratio remained stable over the observation period, while the median age at diagnosis decreased from 61 to 58 years in men and from 66 years to 61 years in women. ASIR were consistently higher for men compared with women, with the yearly difference remaining stable over time (2012: 18%; 2021: 20%). An overall decreasing trend in ASIR was observed during the study period, with a strong decrease from 2012 to 2017, followed by a less pronounced decline from 2018 to 2021 for both sexes. For men, ASIR decreased from 1514 per 100,000 person-years in 2012 to 995 per 100,000 person-years in 2021 (4.6% average annual reduction), and for women from 1238 per 100,000 person-years in 2012 to 796 per 100,000 person-years in 2021 (4.8% average annual reduction). This downward trend was also observed for age groups above 50 years. Regression analyses showed no significant change in incidence rates during the pandemic period (2020 and 2021) compared with the pre-pandemic period. CONCLUSIONS/INTERPRETATION: For the first time, a 10-year incidence trend of type 2 diabetes is reported for Germany, showing a strong decline from 2012 to 2017, followed by a less pronounced decline from 2018 to 2021. The incidence trend of type 2 diabetes appears not to have been affected by the first 2 years of the COVID-19 pandemic. Despite an overall increasing prevalence, the incidence is decreasing, potentially resulting from robust screening by family physicians, reducing the median age at diagnosis by 3 to 5 years. However, further investigation is needed to fully identify the reasons for the declining incidence trend. Continued incidence monitoring is necessary to identify the long-term trend and the potential effect of the pandemic on diagnoses of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“conditions more frequently diagnosed or discussed during this stage of life [38,39].”
From Sociodemographic differences in dementia prevention knowledge in Germany: Implications for targeted health communication (2026) · cites this paper as [38]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“while diabetes [38], higher alcohol consumption [49], and reduced social activity [50] are more prevalent in men [10].”
From Sociodemographic differences in dementia prevention knowledge in Germany: Implications for targeted health communication (2026) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4 · Cited by 33,115
Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., et al. (2019) · Journal of Open Source Software · doi:10.21105/joss.01686 · Cited by 22,138 · cited 1×
“All analyses were conducted in R [14], using the tidyverse framework for data management and the ggplot2 package for creating graphics [15, 16].”
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792
Interrupted time series regression for the evaluation of public health interventions: a tutorial
Lopez Bernal, J., Cummins, S., & Gasparrini, A. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw098 · Cited by 3,049 · cited 2×
“An interrupted time series regression analysis was used to quantify the incidence trend over time and assess a possible pandemic effect by using three different prediction models for ASIR per 100,000 person-years [13].”
MethodChatterjee, S., Khunti, K., & Davies, M. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30058-2 · Cited by 2,577 · cited 1×
“However, type 2 diabetes often develops slowly over the course of several years [41], delaying the direct impact of the pandemic on incidence.”
Sex differences in type 2 diabetes
Kautzky-Willer, A., Leutner, M., & Harreiter, J. (2023) · Diabetologia · doi:10.1007/s00125-023-05891-x · Cited by 624
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., et al. (2021) · JAMA · doi:10.1001/jama.2021.12531 · Cited by 480 · cited 3×
“Therefore, screening for type 2 diabetes seems to be an important step in diabetes prevention since cost-effective interventions (pharmacological and behavioural interventions) show benefits in preventing or delaying the progression of diabetes [35].”
BackgroundGute Praxis Sekundärdatenanalyse (GPS): Leitlinien und Empfehlungen
Swart, E., Gothe, H., Geyer, S., Jaunzeme, J., Maier, B., Grobe, T., & Ihle, P. (2015) · Das Gesundheitswesen · doi:10.1055/s-0034-1396815 · Cited by 445 · cited 1×
“This study was conducted in accordance with the ‘Good Practice of Secondary Data Analysis’ guideline [10].”
MethodPrediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406 · cited 2×
“Additionally, lifestyle interventions also reduce the progression of diabetes [35, 36].”
Trends in incidence of total or type 2 diabetes: systematic review
Magliano, D. J., Islam, R. M., Barr, E. L. M., Gregg, E. W., Pavkov, M. E., Harding, J. L., Tabesh, M., Koye, D. N., & Shaw, J. E. (2019) · BMJ · doi:10.1136/bmj.l5003 · Cited by 346 · cited 4×
“But incidence should also become a standard reporting metric for diabetes, since unlike prevalence, it allows the direct assessment of the effects of changes in risk factors, as it is not influenced by other factors, such as survival [17].”
InfluentialCarr, M. J., Wright, A. K., Leelarathna, L., Thabit, H., Milne, N., Kanumilli, N., Ashcroft, D. M., & Rutter, M. K. (2022) · BMJ Quality & Safety · doi:10.1136/bmjqs-2021-013613 · Cited by 222
Incidence of newly diagnosed diabetes after Covid-19
Rathmann, W., Kuss, O., & Kostev, K. (2022) · Diabetologia · doi:10.1007/s00125-022-05670-0 · Cited by 191
Ye, J., Wu, Y., Yang, S., Zhu, D., Chen, F., Chen, J., Ji, X., & Hou, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1192629 · Cited by 184
Eberle, C., & Stichling, S. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00705-9 · Cited by 181 · cited 1×
“Either a COVID-19 infection itself [37] or disease containment measures possibly altering the impact of lifestyle factors such as physical activity may increase the risk of type 2 diabetes by affecting glycaemic control and thus lead to an increase in type 2 diabetes [38, 39].”
Tamayo, T., Brinks, R., Hoyer, A., Kuß, O., & Rathmann, W. (2016) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2016.0177 · Cited by 178 · cited 1×
“Most studies report incidence rates for the period before 2010, not representing current data [23–25].”
Magliano, D. J., Chen, L., Islam, R. M., Carstensen, B., Gregg, E. W., Pavkov, M. E., Andes, L. J., Balicer, R., Baviera, M., Boersma-van Dam, E., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30402-2 · Cited by 176 · cited 1×
“A systematic review reporting type 2 diabetes incidence on a global level for the first time also revealed decreasing (36% of studies) or stable (30% of studies) incidence trends for most of the included high-and middle-income countries since 2010 [17, 18].”
Projected number of people with diagnosed Type 2 diabetes in Germany in 2040
Tönnies, T., Röckl, S., Hoyer, A., Heidemann, C., Baumert, J., Du, Y., Scheidt‐Nave, C., & Brinks, R. (2019) · Diabetic Medicine · doi:10.1111/dme.13902 · Cited by 145 · cited 3×
“While increasing prevalence trends of type 2 diabetes in Germany suggest a rise in disease burden, incidence data needs to be taken into account [4] for clinical decisions and health system planning.”
InfluentialImpact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK
Carr, M., Wright, A. K., Leelarathna, L., Thabit, H., Milne, N., Kanumilli, N., Ashcroft, D. M., & Rutter, M. K. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00116-9 · Cited by 132
Hajat, S., Haines, A., Sarran, C. E., Sharma, A., Bates, C., & Fleming, L. E. (2017) · Environmental Health · doi:10.1186/s12940-017-0284-7 · Cited by 104 · cited 1×
“In England, peak consultation occurred during hot weather waves [48], whereas in Hungary, incidence of type 2 diabetes was highest in March and lowest in August [46].”
Jacobs, E. M. G., Hoyer, A., Brinks, R., Kuß, O., & Rathmann, W. (2017) · Diabetes Care · doi:10.2337/dc17-0954 · Cited by 93 · cited 3×
“The full Model 1 was significant for both men (F [5;34]=54.4, p <0.05) and women (F [2;37]=81.5, p <0.05), explaining around 87.4% of the variance in ASIR for type 2 diabetes in men and 79.8% of the variance in ASIR for type 2 diabetes in women.”
InfluentialMarçal, I. R., Fernandes, B., Viana, A. A., & Ciolac, E. G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.584642 · Cited by 92 · cited 1×
“Either a COVID-19 infection itself [37] or disease containment measures possibly altering the impact of lifestyle factors such as physical activity may increase the risk of type 2 diabetes by affecting glycaemic control and thus lead to an increase in type 2 diabetes [38, 39].”
Schienkiewitz, A., Kuhnert, R., Blume, M., & Mensink, G. B. M. (2022) · Publication server of the Robert Koch Institute (Robert Kock Institute) · doi:10.25646/10292 · Cited by 91
Trends in Substance Use and Related Disorders
Seitz, N.-N., Lochbühler, K., Atzendorf, J., Rauschert, C., Tim, Pfeiffer-Gerschel, & Kraus, L. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0585 · Cited by 77 · cited 1×
“While the prevalence of smoking decreased from 1995 to 2018 [30], the prevalence of obesity increased from 2012 to 2020 [27].”
BackgroundCost burden of type 2 diabetes in Germany: results from the population-based KORA studies
Ulrich, S., Holle, R., Wacker, M. E., Stark, R. G., Icks, A., Thorand, B., Peters, A., & Laxy, M. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012527 · Cited by 76 · cited 1×
“Healthcare-related direct costs are 1.7 times higher for people living with type 2 diabetes compared to people without diabetes, with increasing direct costs related to cardiovascular complications, type of treatment (insulin vs other glucose-lowering drugs) and disease duration (>20 years) [6].”
InfluentialNational diabetes registries: do they make a difference?
Bak, J. C. G., Serné, E. H., Kramer, M. H. H., Nieuwdorp, M., & Verheugt, C. L. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01576-8 · Cited by 70 · cited 1×
“However, not all of them report HbA 1c measurements, one of the most important values of glycaemic control [7].”
BackgroundBoehme, M. W. J., Buechele, G., Frankenhauser-Mannuss, J., Mueller, J., Lump, D., Boehm, B. O., & Rothenbacher, D. (2015) · BMC Public Health · doi:10.1186/s12889-015-2188-1 · Cited by 60
Rahman, M., Simmons, R. K., Hennings, S., Wareham, N. J., & Griffin, S. J. (2012) · Diabetologia · doi:10.1007/s00125-011-2441-9 · Cited by 56 · cited 2×
“Studies show that people with screening-detected diabetes are diagnosed 3.3 to 4.6 years earlier than clinical-based detection [33, 34].”
InfluentialRKI (2017) · PubMed · doi:10.17886/rki-gbe-2017-062 · Cited by 53 · cited 2×
“The few previous reports from Germany on type 2 diabetes incidence are limited to short observation periods or use data from selected health insurance companies, not allowing for comparison with other European countries [3].”
BackgroundInfluentialSakamoto, M., Matsutani, D., Minato, S., Tsujimoto, Y., Kayama, Y., Takeda, N., Ichikawa, S., Horiuchi, R., Utsunomiya, K., & Nishikawa, M. (2019) · Diabetes Care · doi:10.2337/dc18-1953 · Cited by 50 · cited 1×
“Factors influencing seasonality include physical activity, dietary habits and ambient temperature [45–47].”
BackgroundScreening for type 2 diabetes: do screen-detected cases fare better?
Feldman, A. L., Griffin, S. J., Fhärm, E., Norberg, M., Wennberg, P., Weinehall, L., & Rolandsson, O. (2017) · Diabetologia · doi:10.1007/s00125-017-4402-4 · Cited by 49 · cited 1×
“Studies show that people with screening-detected diabetes are diagnosed 3.3 to 4.6 years earlier than clinical-based detection [33, 34].”
InfluentialEpping, J., Geyer, S., Eberhard, S., & Tetzlaff, J. (2021) · Das Gesundheitswesen · doi:10.1055/a-1553-3565 · Cited by 45
Richter, A., Schienkiwitz, A., Starker, A., Krug, S., Domańska, O. M., Kuhnert, R., Loss, J., & Mensink, G. (2021) · Publication server of the Robert Koch Institute (Robert Kock Institute) · doi:10.25646/8460 · Cited by 42 · cited 2×
“Less than half of the adults (51.2% men and 44.8% women) reached the WHO recommendation of at least 2.5 h of aerobic physical activity per week before the pandemic [31] and 24% of adults reported reducing physical activity during the pandemic period in 2021 [32].”
BackgroundInfluentialAdministrative Prävalenzen und Inzidenzen des Diabetes mellitus von 2009 bis 2015
Goffrier, B., Schulz, M., & Bätzing-Feigenbaum, J. (2017) · Zentralinstitut für die kassenärztliche Versorgung in der Bundesrepublik Deutschland (Zi) · doi:10.20364/va-17.03 · Cited by 42
Inzidenz und Prävalenz von Diabetes mellitus Typ 2 in Deutschland
Wilke, T., Ahrendt, P., Schwartz, D. R., Linder, R., Ahrens, S., & Verheyen, F. (2013) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0032-1327394 · Cited by 33 · cited 2×
“Most studies report incidence rates for the period before 2010, not representing current data [23–25].”
Seasonality in the incidence of type 2 diabetes: a population-based study.
Doró, P., Benkő, R., Matúz, M., & Soós, G. (2006) · PubMed · Cited by 27
Stauder, J., & Kossow, T. (2016) · Das Gesundheitswesen · doi:10.1055/s-0042-104583 · Cited by 26 · cited 1×
“However, the data do not include the privately insured and typically high-income population (10– 15% of the Bavarian population), who may have lower rates of diabetes than the general population [43].”
BackgroundSeasonality in the Incidence of Type 2 Diabetes
Doró, P., Benkő, R., Matuz, M., & Soós, G. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1839 · Cited by 25 · cited 1×
“In England, peak consultation occurred during hot weather waves [48], whereas in Hungary, incidence of type 2 diabetes was highest in March and lowest in August [46].”
BackgroundReitzle, L., Heidemann, C., Jacob, J., Pawlowska-Phelan, D., Ludwig, M., & Scheidt‐Nave, C. (2023) · PubMed Central · doi:10.25646/11730 · Cited by 22
Paprott, R., Mensink, G., Schulze, M. B., Thiele, S., Mühlenbruch, K., Scheidt‐Nave, C., & Heidemann, C. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013058 · Cited by 20 · cited 1×
“A decrease in type 2 diabetes risk could be observed in Germany from 1997 to 1999 and 2008 to 2011, with the reductions in the consumption of red meat and waist circumference suggested as the main drivers [28].”
Spatio-temporal trends in the incidence of type 2 diabetes in Germany
Tönnies, T., Hoyer, A., Brinks, R., Kuss, O., Hering, R., & Schulz, M. (2023) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2022.0405 · Cited by 19 · cited 2×
“…based on nationwide health claims data supports our results, also observing a decrease in incidence trend from 2014 to 2019 by 2.4% for women and 1.7% for men, with lower rates of 8.4 for men and 6.9 per 1000 people for women in 2014 and 7.7 for men and 6.1 per 1000 people for women in 2019 [20].”
BackgroundResultInfluentialRaphael, A., Friger, M. D., & Biderman, A. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.11.013 · Cited by 17 · cited 1×
“Factors influencing seasonality include physical activity, dietary habits and ambient temperature [45–47].”
Manz, K., & Krug, S. (2022) · Publication server of the Robert Koch Institute (Robert Kock Institute) · doi:10.25646/10665 · Cited by 9
Reitzle, L., Heidemann, C., Jacob, J., Pawlowska-Phelan, D., Ludwig, M., & Scheidt‐Nave, C. (2023) · Publication server of the Robert Koch Institute (Robert Kock Institute) · doi:10.25646/11703 · Cited by 9
Gesundheitliche Lage der Bevölkerung zu Beginn der COVID-19-Pandemie
Damerow, S., Rommel, A., Prütz, F., Beyer, A.-K., Hapke, U., Schienkiewitz, A., Starker, A., Richter, A., Baumert, J., Fuchs, J., et al. (2020) · Robert-Koch-Institut (RKI) · doi:10.25646/7171.2 · Cited by 7
Research works printed but not linked: 2
- International Diabetes Federation (2021) IDF Diabetes Atlas, 10th edn. International Diabetes Federation, Brussels, Belgium
- Pace M, Lanzieri G, Glickman M et al (2013) Revision of the European standard population. Eurostat Methodologies and Working Papers. 10.2785/11470 · doi:10.2785/11470
Cited by
Young‐onset type 2 diabetes—Epidemiology, pathophysiology, and management
Luk, A. O. Y., Wu, H., Fan, Y., Fan, B., O, C. K., & Chan, J. C. N. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70081 · Cited by 13
“In Bavaria, Germany, the incidence of type 2 diabetes was stable in individuals younger than 50 years but declined in those older than 50 years between 2012 and 2021 23 .”
Chen, M., Dou, C., Ye, C., Kong, L., Xu, M., Xu, Y., Li, M., Zhao, Z., Zheng, J., Lu, J., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16173 · Cited by 10
Schmitz, T., Freuer, D., Linseisen, J., & Meisinger, C. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.11.004 · Cited by 5
“This is mainly in accordance with known differences in comorbidities and life-style habits in the general German population [43,44], but the variation between men and women might be more pronounced in our study sample.”
Mertens, P. R., Kanaan, M. R., Abou-Watfa, A. A., Bender, S. T., Wiech, T., Gröne, H., & Scurt, F. G. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04617-y · Cited by 4
Koch-Institut, R. (2025) · Europe PMC (PubMed Central) · doi:10.25646/13381 · Cited by 3
“Another study found no significant difference in incidence rates in the 2020 to 2021 pandemic phase compared to the 2012 to 2019 pre-pandemic phase, but did observe a less pronounced decline in incidence in the 2018 to 2021 period compared to the 2012 to 2017 period [ 17 ].”
Influential
Metadata
- Authors
- Lehner, C. T., Eberl, M., Donnachie, E., Tanaka, L. F., Schauberger, G., Schederecker, F., Himmler, S., Sundmacher, L., & Klug, S. J.
- Affiliations
- Technical University of Munich (DE)
- Corresponding author
- Klug, Stefanie J.
- ORCID
- Venue
- Diabetologia
- Published
- 2024-02-26
- Volume
- 67
- Issue
- 6
- Pages
- 1040-1050
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC11058936
- OpenAlex
- W4392159140
- Cited by
- 18
- References
- 44
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 4
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Update notices
- correction (2025-06-17)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PUBLISSO (German National Library of Medicine) (submittedVersion, cc-by)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (458556631)
- Technische Universität München
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, incidence trends, COVID-19 pandemic, sex differences, age at diagnosis, Bavaria, statutory health insurance claims, age-standardized incidence rate, sex ratio, seasonal variation, regional variation, health insurance claims data, underdiagnosis in women
- MeSH terms
- COVID-19, Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Female, Germany, Humans, Insurance, Health, Male, Middle Aged, Incidence, Young Adult, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.